The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): Results from phase i and scientific opportunities in phase II

Barbara L. Kroner, H. Eser Tolunay, Craig T. Basson, Reed E. Pyeritz, Kathryn Holmes, Cheryl Maslen, Dianna M. Milewicz, Scott A. Lemaire, Tabitha Hendershot, Patrice Desvigne-Nickens, Richard B. Devereux, Harry C. Dietz, Howard Song, Danny Ringer, Megan Mitchell, Jonathan W. Weinsaft, William Ravekes, Victor Menashe, Kim A. Eagle

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

Background: Genetically triggered thoracic aortic conditions (GenTACs) represent an important problem for patients and their families. Accordingly, the National Heart, Lung, and Blood Institute established the first phase of its national GenTAC Registry in 2006. Enrollment and Diagnoses: Between 2007 and 2010, 6 enrolling centers established the GenTAC I Registry consisting of 2,046 patients (Marfan syndrome 576 [28.2%], bicuspid aortic valve disease 504 [24.6%], aneurysm or dissection age

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this